London
· Delayed Price · Currency is GBP · Price in GBX GSK plc Statistics
Total Valuation
GSK plc has a market cap or net worth of GBP 60.68 billion. The enterprise value is 72.76 billion.
| Market Cap | 60.68B |
| Enterprise Value | 72.76B |
Important Dates
The next estimated earnings date is Monday, April 28, 2025.
| Earnings Date | Apr 28, 2025 |
| Ex-Dividend Date | Feb 20, 2025 |
Share Statistics
GSK plc has 4.08 billion shares outstanding. The number of shares has increased by 0.75% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 4.08B |
| Shares Change (YoY) | +0.75% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 87.49% |
| Float | 3.94B |
Valuation Ratios
The trailing PE ratio is 23.93 and the forward PE ratio is 8.83. GSK plc's PEG ratio is 1.31.
| PE Ratio | 23.93 |
| Forward PE | 8.83 |
| PS Ratio | 1.93 |
| PB Ratio | 4.44 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.77 |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.31 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.54, with an EV/FCF ratio of 14.11.
| EV / Earnings | 28.26 |
| EV / Sales | 2.32 |
| EV / EBITDA | 8.54 |
| EV / EBIT | 11.77 |
| EV / FCF | 14.11 |
Financial Position
The company has a current ratio of 0.78, with a Debt / Equity ratio of 1.30.
| Current Ratio | 0.78 |
| Quick Ratio | 0.50 |
| Debt / Equity | 1.30 |
| Debt / EBITDA | 1.99 |
| Debt / FCF | 3.30 |
| Interest Coverage | 10.06 |
Financial Efficiency
Return on equity (ROE) is 22.80% and return on invested capital (ROIC) is 12.70%.
| Return on Equity (ROE) | 22.80% |
| Return on Assets (ROA) | 6.52% |
| Return on Invested Capital (ROIC) | 12.70% |
| Return on Capital Employed (ROCE) | 16.37% |
| Revenue Per Employee | 457,183 |
| Profits Per Employee | 37,521 |
| Employee Count | 68,629 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 1.58 |
Taxes
In the past 12 months, GSK plc has paid 754.00 million in taxes.
| Income Tax | 754.00M |
| Effective Tax Rate | 14.39% |
Stock Price Statistics
The stock price has decreased by -12.71% in the last 52 weeks. The beta is 0.29, so GSK plc's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | -12.71% |
| 50-Day Moving Average | 1,455.93 |
| 200-Day Moving Average | 1,470.48 |
| Relative Strength Index (RSI) | 50.96 |
| Average Volume (20 Days) | 10,326,323 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GSK plc had revenue of GBP 31.38 billion and earned 2.58 billion in profits. Earnings per share was 0.62.
| Revenue | 31.38B |
| Gross Profit | 22.53B |
| Operating Income | 6.18B |
| Pretax Income | 3.48B |
| Net Income | 2.58B |
| EBITDA | 8.31B |
| EBIT | 6.18B |
| Earnings Per Share (EPS) | 0.62 |
Balance Sheet
The company has 4.33 billion in cash and 16.99 billion in debt, giving a net cash position of -12.66 billion or -3.11 per share.
| Cash & Cash Equivalents | 4.33B |
| Total Debt | 16.99B |
| Net Cash | -12.66B |
| Net Cash Per Share | -3.11 |
| Equity (Book Value) | 13.09B |
| Book Value Per Share | 3.35 |
| Working Capital | -4.70B |
Cash Flow
In the last 12 months, operating cash flow was 6.55 billion and capital expenditures -1.40 billion, giving a free cash flow of 5.16 billion.
| Operating Cash Flow | 6.55B |
| Capital Expenditures | -1.40B |
| Free Cash Flow | 5.16B |
| FCF Per Share | 1.26 |
Margins
Gross margin is 71.81%, with operating and profit margins of 19.71% and 8.21%.
| Gross Margin | 71.81% |
| Operating Margin | 19.71% |
| Pretax Margin | 11.08% |
| Profit Margin | 8.21% |
| EBITDA Margin | 26.49% |
| EBIT Margin | 19.71% |
| FCF Margin | 16.43% |
Dividends & Yields
This stock pays an annual dividend of 0.61, which amounts to a dividend yield of 4.13%.
| Dividend Per Share | 0.61 |
| Dividend Yield | 4.13% |
| Dividend Growth (YoY) | 5.17% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 94.91% |
| Buyback Yield | -0.75% |
| Shareholder Yield | 3.37% |
| Earnings Yield | 4.24% |
| FCF Yield | 8.50% |
Stock Splits
The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8.
| Last Split Date | Jul 19, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.8 |
Scores
GSK plc has an Altman Z-Score of 1.81 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.81 |
| Piotroski F-Score | 7 |